These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer. Demirkol MO; Kiremit MC; Acar O; Ucar B; Saglican Y Clin Nucl Med; 2017 May; 42(5):403-405. PubMed ID: 28319496 [TBL] [Abstract][Full Text] [Related]
63. Detection Rate and Localization of Prostate Cancer Recurrence Using Kranzbühler B; Müller J; Becker AS; Garcia Schüler HI; Muehlematter U; Fankhauser CD; Kedzia S; Guckenberger M; Kaufmann PA; Eberli D; Burger IA J Nucl Med; 2020 Feb; 61(2):194-201. PubMed ID: 31375566 [TBL] [Abstract][Full Text] [Related]
64. (68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. Sterzing F; Kratochwil C; Fiedler H; Katayama S; Habl G; Kopka K; Afshar-Oromieh A; Debus J; Haberkorn U; Giesel FL Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):34-41. PubMed ID: 26404016 [TBL] [Abstract][Full Text] [Related]
65. [(68)Ga-PSMA as a new tracer for evaluation of prostate cancer: comparison between PET-CT and PET-MRI in biochemical recurrence]. Avanesov M; Karul M; Derlin T Radiologe; 2015 Feb; 55(2):89-91. PubMed ID: 25583413 [No Abstract] [Full Text] [Related]
66. Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study. Çelen S; Gültekin A; Özlülerden Y; Mete A; Sağtaş E; Ufuk F; Yüksel D; Yağcı B; Zümrütbaş AE Urol Int; 2020; 104(9-10):684-691. PubMed ID: 32750695 [TBL] [Abstract][Full Text] [Related]
67. Extraosseous Extension of Aggressive Vertebral Hemangioma as a Potential Pitfall on 68Ga-PSMA PET/CT. Probst S; Bladou F; Abikhzer G Clin Nucl Med; 2017 Aug; 42(8):624-625. PubMed ID: 28632693 [TBL] [Abstract][Full Text] [Related]
72. 68Ga PSMA PET/CT in a Rare Case of Metastatic Adenocarcinoma Prostate Presenting as Numb Chin Syndrome. Sasikumar A; Joy A; Pillai MR; Gopal R; Thomas B Clin Nucl Med; 2017 Mar; 42(3):e161-e162. PubMed ID: 28045729 [TBL] [Abstract][Full Text] [Related]
73. Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence. Zacho HD; Nielsen JB; Dettmann K; Haberkorn U; Petersen LJ Clin Nucl Med; 2017 Mar; 42(3):221-222. PubMed ID: 28033223 [TBL] [Abstract][Full Text] [Related]
75. The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer. Meyrick DP; Asokendaran M; Skelly LA; Lenzo NP; Henderson A Nucl Med Commun; 2017 Nov; 38(11):956-963. PubMed ID: 28922335 [TBL] [Abstract][Full Text] [Related]
76. PET/CT With Giovacchini G; Giovannini E; Riondato M; Ciarmiello A Curr Radiopharm; 2018; 11(1):4-13. PubMed ID: 29090673 [TBL] [Abstract][Full Text] [Related]
77. Synchronous Detection of Male Breast Cancer and Prostatic Cancer in a Patient With Suspected Prostatic Carcinoma on 68Ga-PSMA PET/CT Imaging. Kumar R; Mittal BR; Bhattacharya A; Singh H; Singh SK Clin Nucl Med; 2018 Jun; 43(6):431-432. PubMed ID: 29538032 [TBL] [Abstract][Full Text] [Related]